Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma

NCT06771544 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Melanoma Stage III
Melanoma (Skin)
Melanoma Stage IV

Interventions

DRUG: Pembrolizumab
DRUG: Cyclophosphamide

Sponsor

University of California, Irvine